In DENV patients, IgE has been associated with developing DHF [20], and MC activation levels (measured using the biomarker chymase) are also higher in DHF patients experiencing secondary infection compared to primary infection [8]. The gene discussed is CMA1; the disease is Dengue hemorrhagic fever.